AxoSim, client and tenant of the New Orleans BioInnovation Center, won the top $100,000 investment prize at the Coulter IDEAPitch. AxoSim has created a patented “nerve-on-a-chip” technology that helps pharmaceutical companies discover new drugs. AxoSim’s technology will drastically reduce the time and money required to discover new treatments for neurodegenerative diseases such as ALS and MS. This technology can also test the neurotoxic side-effects of chemotherapy treatments and similar drugs, all while minimizing inaccurate animal testing. AxoSim plans to build a personalized medicine platform that will be the future of drug discovery and treatment, and they plan to build it in New Orleans. They’ve already created over half a dozen high-tech jobs for the local economy and they’re just getting started.

Congratulations AxoSim!